SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Inadequate evidence to support phase III studies of albumin in severe malaria.

Woodrow, CJ; Planche, T (2007) Inadequate evidence to support phase III studies of albumin in severe malaria. PLOS CLINICAL TRIALS, 2 (2). ISSN 1555-5887 https://doi.org/10.1371/journal.pctr.0020004
SGUL Authors: Woodrow, Charles Jonathan Planche, Timothy David

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (69kB) | Preview
Item Type: Article
Additional Information: PubMed ID: 17290301. No abstract. © 2007 Woodrow and Planche. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Science & Technology, Life Sciences & Biomedicine, Medicine, Research & Experimental, Pharmacology & Pharmacy, Research & Experimental Medicine, VOLUME EXPANSION, TRIAL, CHILDREN
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: PLOS CLINICAL TRIALS
ISSN: 1555-5887
Related URLs:
Dates:
DateEvent
9 February 2007Published
Web of Science ID: WOS:000245239800001
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/1958
Publisher's version: https://doi.org/10.1371/journal.pctr.0020004

Actions (login required)

Edit Item Edit Item